Ipamorelin: The Selective Secretagogue on the Ghrelin Pathway Ipamorelin is a selective growth hormone secretagogue that binds to the ghrelin receptor on the same pituitary cells targeted by CJC-1295
CJC-1295/Ipamorelin uses dual-pathway activation producing more sustained GH release, more consistent IGF-1 elevation, and more pronounced results at the 3-6 month mark
increased Glutathione means we can reach that deep sleep our mind needs for cognitive recovery through the night
Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow
Efficacy and safety of dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sufonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial